carbapenems has been researched along with Endocarditis, Bacterial in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (11.11) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hollenberg, SM; Khan, ZA | 1 |
Augustine, JJ; Bonomo, RA; Hujer, AM; Jacobs, GH; Jacobs, MR; Patel, G; Perez, F; Rudin, SD | 1 |
Adler, A; Benenson, S; Block, C; Carmeli, Y; Moses, AE; Navon-Venezia, S; Strahilevitz, J | 1 |
Rajdev, S; Shivaprakasha, S; Singh, H; Velivala, S | 1 |
Gudiol, F; Marín, M | 1 |
Hirai, Y; Kijima, K; Kurazono, M; Nagura, J; Shitara, E; Sugano, T; Takahata, S; Takayama, Y; Tanaka, Y; Yamada, K; Yonezawa, M | 1 |
Chambers, HF | 1 |
Bergogne-Bérézin, E | 1 |
Dornbusch, K; Henning, C; Lindén, E | 1 |
2 review(s) available for carbapenems and Endocarditis, Bacterial
Article | Year |
---|---|
Valvular Heart Disease in Adults: Infective Endocarditis.
Topics: Anti-Bacterial Agents; Blood Culture; Carbapenems; Cefepime; Cephalosporins; Cross Infection; Echocardiography; Endocarditis; Endocarditis, Bacterial; Gentamicins; Heart Valve Prosthesis; Humans; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Vancomycin | 2017 |
[Resistance and new antibiotic strategies. New antistaphylococcal antibiotics].
Topics: Anti-Infective Agents; Carbapenems; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Fluoroquinolones; Humans; Methicillin Resistance; Staphylococcal Infections; Virginiamycin | 2000 |
7 other study(ies) available for carbapenems and Endocarditis, Bacterial
Article | Year |
---|---|
Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Postoperative Complications | 2015 |
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Treatment Outcome | 2009 |
Prosthetic aortic valve endocarditis due to Ochrobactrum anthropi.
Topics: Aged; Aortic Valve; Carbapenems; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Male; Ochrobactrum anthropi | 2011 |
[beta-Lactam antibiotics].
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cephalosporins; Endocarditis, Bacterial; Humans; Molecular Structure; Monobactams; Neutropenia; Penicillins; Respiratory Tract Infections; Soft Tissue Infections; Staphylococcal Skin Infections; Urinary Tract Infections | 2003 |
Therapeutic effect of ME1036 on endocarditis experimentally induced by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Disease Models, Animal; Endocarditis, Bacterial; Female; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2005 |
In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a.
Topics: Animals; Bacterial Proteins; Carbapenems; Carrier Proteins; Cell Wall; Endocarditis, Bacterial; Hexosyltransferases; Imidazoles; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
In-vitro activity of the new penems FCE 22101 and FCE 24362 alone or in combination with aminoglycosides against streptococci isolated from patients with endocarditis.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Synergism; Endocarditis, Bacterial; Gentamicins; Humans; Lactams; Microbial Sensitivity Tests; Netilmicin; Streptococcus; Time Factors | 1989 |